13th Process Development for Highly Potent Drugs Summit (HPAPI)
Evvnt Promotion / evvnt
25.06.2024 - 27.06.2024 Delta Hotel Philadelphia Airport, 500 Stevens Drive, 19113 Philadelphia, Pennsylvania, USA
Time: 1:30 PM - 3:45 PM
Kongressthemen
From Process Safety to Rapid Scale-Up to Tech Transfer: Integrating Process Development, Industrial Hygiene and Equipment Selection to Achieve GMP Manufacturing of Novel High Potent Drug Compounds 2023 has been a pivotal year for novel high potent compounds securing early success and approvals – from Henlius’s ADC to Gilead’s Trodelvy to BMS’s Augtyro, cementing the growth of highly potent drugs market to reach USD$40.7bn by 2023.
From Process Safety to Rapid Scale-Up to Tech Transfer: Integrating Process Development, Industrial Hygiene and Equipment Selection to Achieve GMP Manufacturing of Novel High Potent Drug Compounds 2023 has been a pivotal year for novel high potent compounds securing early success and approvals – from Henlius’s ADC to Gilead’s Trodelvy to BMS’s Augtyro, cementing the growth of highly potent drugs market to reach USD$40.7bn by 2023.
Kongressorganizer (PCO)
Hanson Wade Group
Hanson Wade Group
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2316046-3?pid=4832
Speakers: Antonio Hernandez-Cardoso, Senior Principal Scientist, US Pharmacopiea, and more
URL:
Brochure: https://go.evvnt.com/2316046-3?pid=4832
Speakers: Antonio Hernandez-Cardoso, Senior Principal Scientist, US Pharmacopiea, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2316046-2?pid=4832
Frau Gracia Carr
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 2599.00 - USD 5197.00
USD 2599.00 - USD 5197.00
Teilnehmer erwartet
1000 - 1000
1000 - 1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
